Related references
Note: Only part of the references are listed.Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach
Lovika Mittal et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
Ammar D. Elmezayen et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
A novel coronavirus outbreak of global health concern
Chen Wang et al.
LANCET (2020)
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Canrong Wu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design
Maria Bzowka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
Bhupesh Goyal et al.
ACS COMBINATORIAL SCIENCE (2020)
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
Catrin Sohrabi et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19
Sirle Saul et al.
ACS INFECTIOUS DISEASES (2020)
Structure-based drug designing and immunoinformatics approach for SARS-CoV-2
Pritam Kumar Panda et al.
SCIENCE ADVANCES (2020)
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
Laura Riva et al.
NATURE (2020)
In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation
M. Iqbal Choudhary et al.
PLOS ONE (2020)
Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19
Lorane Izabel da Silva Hage-Melim et al.
LIFE SCIENCES (2020)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Benchmark of four popular virtual screening programs: construction of the active/decoy dataset remains a major determinant of measured performance
Ludovic Chaput et al.
JOURNAL OF CHEMINFORMATICS (2016)
Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
Yasuhiro Shimamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Covalent docking of large libraries for the discovery of chemical probes
Nir London et al.
NATURE CHEMICAL BIOLOGY (2014)
Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding
Mark Turlington et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases
Chi-Pang Chuck et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease
Jon Jacobs et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
Lili Zhu et al.
ANTIVIRAL RESEARCH (2011)
GSK256066, an Exceptionally High-Affinity and Selective Inhibitor of Phosphodiesterase 4 Suitable for Administration by Inhalation: In Vitro, Kinetic, and In Vivo Characterization
Cathy J. Tralau-Stewart et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds
Cheng-Chung Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Identifying and Characterizing Binding Sites and Assessing Druggability
Thomas A. Halgren
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Structure-based design,synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors
Arun K. Ghosh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus
D. H. Goetz et al.
BIOCHEMISTRY (2007)
Crystal structures reveal an induced-fit binding of a substrate-like aza-peptide epoxide to SARS coronavirus main peptidase
Ting-Wai Lee et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
New method for fast and accurate binding-site identification and analysis
Tom Halgren
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease
I-Lin Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor
Syaulan Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease
CY Wu et al.
CHEMISTRY & BIOLOGY (2006)
Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide
TW Lee et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors
AK Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Design of wide-spectrum inhibitors targeting coronavirus main proteases
HT Yang et al.
PLOS BIOLOGY (2005)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
HT Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Virus-encoded proteinases and proteolytic processing in the Nidovirales
J Ziebuhr et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Share Paper
